| Rishabh Gulati, MD | |
|
3261 Nw Mount Vintage Way Ste 221, Silverdale, WA 98383-6039 | |
| (360) 479-1952 | |
| (360) 479-0318 |
| Full Name | Rishabh Gulati |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 12 Years |
| Location | 3261 Nw Mount Vintage Way Ste 221, Silverdale, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649688698 | NPI | - | NPPES |
| 2162030 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD61000957 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison Medical Center | Bremerton, WA | Hospital |
| Jefferson Healthcare | Port townsend, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Gastroenterology Pllc | 6204194848 | 115 |
News Archive
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing.
Learning a language later in life changes how the two halves of the brain contribute. As skills improve, language comprehension changes hemisphere specialization, but production does not, according to new research published in JNeurosci.
› Verified 1 days ago
| Entity Name | Washington Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306364401 PECOS PAC ID: 6204194848 Enrollment ID: O20180103000884 |
News Archive
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing.
Learning a language later in life changes how the two halves of the brain contribute. As skills improve, language comprehension changes hemisphere specialization, but production does not, according to new research published in JNeurosci.
› Verified 1 days ago
| Entity Name | Digestive Health Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265942346 PECOS PAC ID: 9436410115 Enrollment ID: O20180220001196 |
News Archive
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing.
Learning a language later in life changes how the two halves of the brain contribute. As skills improve, language comprehension changes hemisphere specialization, but production does not, according to new research published in JNeurosci.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rishabh Gulati, MD 3261 Nw Mount Vintage Way Ste 221, Silverdale, WA 98383-6039 Ph: (360) 479-1952 | Rishabh Gulati, MD 3261 Nw Mount Vintage Way Ste 221, Silverdale, WA 98383-6039 Ph: (360) 479-1952 |
News Archive
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing.
Learning a language later in life changes how the two halves of the brain contribute. As skills improve, language comprehension changes hemisphere specialization, but production does not, according to new research published in JNeurosci.
› Verified 1 days ago
Jose Jeffrey Turtal Reasol, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 Fax: 360-307-7336 | |
Tetyana Mcilvaine, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 9177 Ridgetop Blvd Nw, Silverdale, WA 98383 Phone: 360-307-6961 | |
Dr. Melike Arslan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1950 Nw Myhre Rd, Fl 3, Silverdale, WA 98383 Phone: 564-240-4200 Fax: 564-240-4299 | |
Snehal R. Bansod, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1950 Nw Myhre Rd Fl 2, Silverdale, WA 98383 Phone: 564-240-4080 Fax: 564-240-4088 | |
Dmitry Tsimberov, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 | |
Dr. William Michael Hall, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2011 Nw Myhre Pl, Silverdale, WA 98383 Phone: 360-830-1600 | |
Sujeen Adhikari, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1950 Nw Myhre Rd Fl 3, Silverdale, WA 98383 Phone: 564-240-4200 Fax: 564-240-4299 |